Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daktari Diagnostics
Cambridge, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Daktari Diagnostics developed and validated a portable, microfluidics-based point-of-care platform for HIV (CD4 count), HCV, and sickle cell disease, enabling rapid diagnostics in resource-limited settings. The company achieved prototype and pilot milestones, including partnership with Merck for HCV device development, but did not achieve broad commercial scale.
- Therapeutic areas
- HematologyInfectious Diseases
- Modalities
- Device
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Merck (Merck Global Health Innovation Fund)
Beyond the preview
Go deeper on Daktari Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daktari Diagnostics.